Transarterial Chemoembolization (TACE) Combined with Sorafenib <i>versus</i> TACE Alone for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Study

Ren, Baosheng; Wang, Wansheng; Shen, Jian; Li, Wan-Ci; Ni, Caifang; Zhu, Xiaoli

doi:10.7150/jca.28994

Public

Transarterial Chemoembolization (TACE) Combined with Sorafenib versus TACE Alone for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Study

Published in Journal of Cancer • Jan 1, 2019

Authors:

Baosheng Ren

Wansheng Wang

Jian Shen

Abstract

Objective: To compare the outcomes of transarterial chemoembolization (TACE) combined with sorafenib versus TACE alone for treating patients with unresectable hepatocellular carcinoma (HCC). Methods: This retrospective analysis included all patients receiving either TACE plus sorafenib therapy or TA...

Subject

Propensity score matching

Sorafenib

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!